Skip to main content
ALHCAlignment Healthcare, Inc.Sell5.9·$19.75-2.42%
Open full analysis

Alignment Healthcare, Inc. (ALHC) Stock Analysis

Breakout setup

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Healthcare Plans

Sell if holding. Engine safety override at $19.75: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.9/10. Specifically: High short interest: 13%; Below-average business quality.

Alignment Healthcare offers Medicare Advantage plans to seniors in 45 markets across California, North Carolina, Nevada, Arizona, and Texas, with 236,300 members as of December 31, 2025. Revenue comes via capitated per-member-per-month CMS payments; the company earned its 36%... Read more

$19.75+9.8% A.UpsideScore 5.9/10#1 of 11 Healthcare Plans
QualityF-score7 / 9FCF yield5.75%
Stop $18.37Target $21.68(analyst − 13%)A.R:R 0.7:1
Analyst target$24.92+26.2%13 analysts
$21.68our TP
$19.75price
$24.92mean
$16
$30

Sell if holding. Engine safety override at $19.75: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.9/10. Specifically: High short interest: 13%; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 65, MACD bullish. Score 5.9/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 46d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About Alignment Healthcare, Inc.

About Alignment Healthcare, Inc.

Alignment Healthcare enrolled 236,300 Medicare Advantage members across 45 markets as of December 31, 2025, having grown from approximately 13,000 at inception in 2013 at a 30% compound annual growth rate. The company operates in California (22 markets), North Carolina (16 markets), Arizona (3 markets), Nevada (2 markets), and Texas (2 markets), covering approximately 8.4 million Medicare-eligible seniors. Five-year compound revenue growth through December 31, 2025 reached 36%.

Alignment earns revenue through fixed capitated per-member-per-month (PMPM) payments from the Centers for Medicare & Medicaid Services (CMS) under Medicare Advantage contracts. Payment rates vary by county-level benchmarks, member health risk scores, and CMS Star Ratings; plans rated 4.0 Stars or higher receive benchmark increases that allow richer supplemental benefits. Approximately 100% of members were enrolled in 4.0 Star-rated plans for the 2026 rating year and 2027 payment year. Rather than relying on prior authorization and administrative cost controls common to traditional health insurers, Alignment deploys its Care Anywhere program, staffed by more than 450 full-time clinical employees — roughly 25% of its total workforce — including employed physicians, advanced practice clinicians, case managers, social workers, and behavioral health coaches. These clinicians target the 14% of members classified as "chronic," who account for 78% of institutional claims. The proprietary AVA platform ingests longitudinal data from more than 200 sources, generating prescriptive care interventions and predicting hospital admission and re-admission risk.

Show full overview

CMS annually updates Star Ratings methodology, creating a revenue threshold at the 4.0-Star boundary. In 2024, CMS removed performance outliers via the Turkey outlier deletion method, raising cut points industry-wide; the 2026 Star ratings cycle yielded only 18 five-star MA-Part D contracts, down from 57 in 2023. Alignment's CMS contracts each carry a one-year term expiring December 31 of the applicable calendar year, subject to annual renewal — meaning a single adverse Star rating action or contract termination could immediately affect any of the company's 45 markets.

See also: Healthcare · Healthcare Plans

From Alignment Healthcare, Inc.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-14

Recent Developments — Alignment Healthcare, Inc.

Generated 2026-06-15T18:11:46Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 30, 202646d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Customer: CMS contracts
Quality below floor (3.9 < 4.0)
Value-trap signals (2/5): Margin compression (op margin -0.2%), Material insider selling (8 sells, 0.03% of cap)

Key Metrics

P/E (TTM)197.5
P/E (Fwd)27.3
Mkt Cap$4.1B
EV/EBITDA54.9
Profit Mgn0.5%
ROE12.5%
Rev Growth33.3%
Beta1.15
DividendNone
Rating analysts20

Quality Signals

Piotroski F7/9

Options Flow

P/C0.88neutral
IV91%elevated
Max Pain$25+26.6% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHCustomerCMS contracts
    10-K Item 1: 'We currently derive substantially all of our revenue from CMS contracts related to our Medicare Advantage health plans.'
  • MEDIUMGeographiclimited number of U.S. states
    10-K Item 1A: 'Our plans are concentrated in a limited number of U.S. states and we may not be able to establish new geographic presences.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.9
Support Resistance
1.8
52w Position
6.5

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Net Margin
0.2
Operating Margin
0.5
Roa
1.4
Roe
4.2
Moat
5.4
Current Ratio
5.7
Piotroski F
7.8
Fcf Quality
10.0
Excellent cash conversion: 1000% FCF/NINo competitive moatStrong Piotroski F-Score: 7/9
GatesA.R:R 0.7 < 1.5@spotMomentum 7.1>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 46d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
65 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $13.05Resistance $21.25

Price Targets

$18
$22
A.Upside+9.8%
A.R:R0.7:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.9 < 4.0)
! Value-trap signals (2/5): Margin compression (op margin -0.2%), Material insider selling (8 sells, 0.03% of cap)
! asymmetry at 0.7 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-30 (46d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ALHC stock a buy right now?

Sell if holding. Engine safety override at $19.75: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.9/10. Specifically: High short interest: 13%; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 65, MACD bullish. Prior stop was $18.37. Score 5.9/10, moderate confidence.

What is the ALHC stock price target?

Take-profit target: $21.68 (+9.8% upside). Prior stop was $18.37. Stop-loss: $18.37.

What are the risks of investing in ALHC?

Concentration risk — Customer: CMS contracts; Quality below floor (3.9 < 4.0); Value-trap signals (2/5): Margin compression (op margin -0.2%), Material insider selling (8 sells, 0.03% of cap).

Is ALHC overvalued or undervalued?

Alignment Healthcare, Inc. trades at a P/E of 197.5 (forward 27.3). TrendMatrix value score: 6.0/10. Verdict: Sell.

What do analysts say about ALHC?

20 analysts cover ALHC with a consensus score of 4.3/5. Average price target: $25.

What does Alignment Healthcare, Inc. do?Alignment Healthcare offers Medicare Advantage plans to seniors in 45 markets across California, North Carolina,...

Alignment Healthcare offers Medicare Advantage plans to seniors in 45 markets across California, North Carolina, Nevada, Arizona, and Texas, with 236,300 members as of December 31, 2025. Revenue comes via capitated per-member-per-month CMS payments; the company earned its 36% five-year compound revenue growth by proactively managing member care through its proprietary AVA technology platform and in-house Care Anywhere clinical teams.

Related stocks: OSCR (Oscar Health, Inc.) · CLOV (Clover Health Investments, Corp) · PGNY (Progyny, Inc.) · CNC (Centene Corporation) · MOH (Molina Healthcare Inc)
Home Stocks ALHC

Latest news

Latest News

Benzinga6d ago
Benzinga34d agoLeadership Change
Benzinga35d ago
Benzinga45d agoAnalyst
Benzinga45d agoAnalyst
Benzinga46d agoEarnings
Benzinga46d agoEarnings
Benzinga46d ago
Benzinga46d agoEarnings
Benzinga69d ago
Benzinga69d ago
Benzinga69d ago